This research is yet another reminder that drugs like Fosamax do have the potential to cause serious side effects. Patients should definitely speak with their doctors about the risks and benefits of these drugs before they begin bisphosphonate therapy.
New York, NY (PRWEB) December 01, 2012
As Fosamax lawsuits continue to move forward, a new study has found that patients who take bisphosphonates like Fosamax may be at increased risk for upper gastrointestinal cancer, Bernstein Liebhard LLP reports. The study compared 8,636 men and women who had a recorded incident of upper gastrointestinal cancer, matched to 34,544 controls with no record of disease. Bisphosphonate use was defined as any patient ever prescribed one during the 13-year study period. Overall, the study saw a 13% increased risk for upper gastrointestinal cancer in those who had taken bisphosphonates compared with patients who had not. The study, which was published in October in the journal “PLOS One,” also found that the effect was particularly strong in women taking bisphosphonates, compared to men. *
“This research is yet another reminder that drugs like Fosamax do have the potential to cause serious side effects. Patients should definitely speak with their doctors about the risks and benefits of these drugs before they begin bisphosphonate therapy,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of drugs and medical devices. The firm is currently offering free lawsuit evaluations to victims of serious Fosamax side effects, including atypical femur fractures.
Bisphosphonates like Fosamax are approved to prevent fractures in people who have bone weakening diseases like osteoporosis and Paget’s disease. In October 2010, the U.S. Food & Drug Administration (FDA) advised that people taking bisphosphonates for osteoporosis are at risk of suffering atypical femur fractures.** Just this past May, an FDA-commissioned analysis published in the New England Journal of Medicine found that there was little benefit in taking bisphosphonates for longer than five years. The report cited the risk of serious Fosamax side effects, including atypical femur fractures, jaw problems and esophageal cancer.***
Hundreds of Fosamax lawsuits are currently pending in a consolidated litigation in New Jersey Superior Court, Atlantic County. Plaintiffs allege long-term use of the drug caused serious Fosamax side effects, including atypical femur fractures. (In re: Fosamax Litigation, No. 282, N.J. Super. Ct.)
Bernstein Liebhard LLP is actively filing Fosamax lawsuits on behalf of individuals who were allegedly injured as a result of taking Fosamax. If you suffered a femur fracture, you may be entitled to compensation for medical bills, pain and suffering, lost wages and other injuries. A wealth of information regarding Fosamax lawsuits is available by visiting Bernstein Liebhard LLP’s website, http://www.consumerinjurylawyers.com/. To arrange for a free case review, please contact Bernstein Liebhard LLP at (877) 779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP